Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 10/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | CASP6 | P55212 | 1/20 | 0.36 |
| ▸ | MGLL | Q99685 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.35 |
| ▸ | MMP13 | P45452 | 1/20 | 0.35 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25588991 | 0.88 | ALDH1A1 (0.37) | HRH3ALDH1A1KDM4EL3MBTL1CASP6 | |
| SCHEMBL21695058 | 0.88 | ALDH1A1 (0.42) | HRH3ALDH1A1KDM4ECASP6MGLL | |
| SCHEMBL20436763 | 0.88 | ALDH1A1 (0.37) | HRH3ALDH1A1KDM4EL3MBTL1CASP6 | |
| SCHEMBL19661326 | 0.86 | CASP6 (0.36) | HRH3ALDH1A1KDM4EL3MBTL1CASP6 | |
| SCHEMBL19661318 | 0.85 | ALDH1A1 (0.34) | HRH3ALDH1A1KDM4EL3MBTL1CASP6 | |
| SCHEMBL21694972 | 0.82 | ALDH1A1 (0.34) | HRH3ALDH1A1KDM4EL3MBTL1CASP6 | |
| SCHEMBL15934091 | 0.82 | KDM4E (0.44) | ALDH1A1KDM4EPOLBSMN1; SMN2HTT | |
| SCHEMBL25589656 | 0.80 | HRH3 (0.41) | HRH3ALDH1A1KDM4EL3MBTL1CASP6 | |
| SCHEMBL15932295 | 0.78 | ALDH1A1 (0.36) | ALDH1A1KDM4EPOLBSMN1; SMN2HTT | |
| SCHEMBL681679 | 0.78 | ALDH1A1 (0.56) | ALDH1A1KDM4ECASP6MGLLPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11384105-B2 | Processes for preparing oligomers | SAREPTA THERAPEUTICS, INC. (US) | 2022-07-12 | — | — | US | disclosed |
| US-20210198296-A1 | PROCESSES FOR PREPARING OLIGOMERS | SAREPTA THERAPEUTICS, INC. (US) | 2021-07-01 | — | — | US | disclosed |
| US-10875880-B2 | Processes for preparing oligomers | SAREPTA THERAPEUTICS, INC. (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200040020-A1 | PROCESSES FOR PREPARING OLIGOMERS | JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT | 2020-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200040020-A1 | PROCESSES FOR PREPARING OLIGOMERS | NOP2, PCBP1, RNGTT | HRH3 4883/4885ALDH1A1 4511/4885KDM4E 4234/4885 |
| US-20210198296-A1 | PROCESSES FOR PREPARING OLIGOMERS | PCBP1, RNGTT, PHAX | HRH3 4880/4885ALDH1A1 4252/4885KDM4E 3847/4885 |
| US-10875880-B2 | Processes for preparing oligomers | NOP2, PCBP1, RNGTT | HRH3 4883/4885ALDH1A1 4511/4885KDM4E 4234/4885 |
| US-11384105-B2 | Processes for preparing oligomers | NOP2, RNGTT, PCBP1 | HRH3 4883/4885ALDH1A1 4482/4885KDM4E 3881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.